Ind-Swift Labs. (INDSWFTLAB)

FairStock Score: 36/100 — MIXED

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At first glance, Ind-Swift Labs looks like a classic Graham low-P/B situation: price ₹137.85, book value ₹116.32, P/B 1.19, and almost no debt. But the first rule is to never confuse a cheap price with value. The reported numbers have improved on paper — sales up 17.12%, profits up 371.85% — yet the ROCE is a terrible 0.78%. That single figure tells me the core business is not earning a satisfactory return on capital employed. A ROE of 24.39% alongside such a low ROCE is a warning: part of the profit may be coming from non-operating or volatile sources, not from durable business economics. As Graham said, the investor must demand a margin of safety. Here the safety is thin because the capital is cheap only if profits can be sustained. The debt/equity of 0.02 and Piotroski score of 7/9 do suggest a cleaner balance sheet and some improving metrics. Promoter holding at 43% is moderate, but there is zero dividend, so shareholders must depend entirely on growth. At a P/E of 25, the market is not giving the stock away. The 52-week range of ₹87.15 to ₹320.50 shows how unpredictable the earnings momentum has been. Overall, this is a possible turnaround, not a compounder. I would wait for ROCE to improve materially and for quarterly profit to be sustained before calling this an opportunity.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer